Coronavirus updates



Defusing vaccine skepticism

Public trust is set to explode, taking pandemic progress with it

One shot

With vaccine skepticism threatening to shatter pandemic progress, pharma can’t afford to falter

Pharma's warp drive

The key factors helping drugmakers develop a vaccine in record time

Because patients can’t wait

How autologous cell therapy companies can adapt planning processes to maintain operations amid supply chain disruptions.

Under pressure: Can the glass packaging industry withstand the weight of COVID-19?

It was all smiles at the White House in 2017 when executives from Corning Incorporated visited President Trump’s administration to unveil an innovative new pharmaceutical vial...

Steering through turbulence with IoT

How pharma can navigate disruptions by applying Internet of Things technology to supply chains

The COVID-19 vaccine: A developing tale of black and cornered markets

If the data and recipes were compromised by a foreign adversary, that could be used to corner markets on ingredients, components and tools. The result could be price gouging the...

Making hydroxychloroquine great again

How a 65-year old drug became the center of partisan divide

Fighting COVID-19 with AI

Pharma companies are using technology to reinvent the drug discovery process

The higher they fly: Managing pharma’s COVID-19 reputation risk

The response to the COVID-19 crisis is casting a bright reputational halo over the entire industry. But if you’re going to fly close to the sun, you’d better be sure your wings...

Global Dose: Focus on Russia

After building its domestic infrastructure, Russia's pharma industry looks to go global

A new kind of FDA meeting

How COVID-19 is changing the way the FDA approaches interactions with industry

These unprecedented timelines

Pharma’s bumpy race towards a vaccine could offer a fresh start

Coronavirus vaccines: The billion dose dash

Can pharma meet its lofty goals for coronavirus vaccine production?

Taking the lead in pandemic preparedness

Pharma can use its pandemic response momentum to set the pace for a more prepared future